Use of ecteinascidin in the treatment of cancer in patients with low level of BRCA1

Details for Australian Patent Application No. 2005261860 (hide)

Owner Pharma Mar, S.A., Sociedad Unipersonal

Inventors Rosell Costa, Rafael; Taron Roca, Miguel; Tercero Lopez, Juan Carlos; Jimeno Donaque, Jose Ma

Agent Fisher Adams Kelly

Pub. Number AU-A-2005261860

PCT Pub. Number WO2006/005602

Priority 04076997.8 09.07.04 EP

Filing date 11 July 2005

Wipo publication date 19 January 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/4995 (2006.01) - Pyrazines or piperazines forming part of bridged ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/005602 Priority application(s): WO2006/005602

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261861-Biochemical synthesis of 1,4-butanediamine

2005261858-Detector for distinguishing phases in a multiphase fluid mixture